Biomarkers Discovery and Novel Diagnostics

The group has to complementary research lines aiming at helping translating basic research to clinical practice.

1) Finding new biomarkers with clinical relevance, using proteomic approaches;

2) R&D of electrochemical biosensors for point-of-care testing of clinical metabolites, such as cardiovascular biomarkers.




Member of:







1 | 2 >>

© 2015 Todos os direitos reservados.

Crie o seu site grátisWebnode